ONC201/TIC10 enhances durability of mTOR inhibitor everolimus in metastatic ER+ breast cancer https://www.biorxiv.org/content/10.1101/2022.12.27.522019v1?med=mas
ONC201/TIC10 enhances durability of mTOR inhibitor everolimus in metastatic ER+ breast cancer https://www.biorxiv.org/content/10.1101/2022.12.27.522019v1?med=mas